Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Rang în acțiuni #13828
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Preț acțiune
$4.36
Capitalizare de piață
$457.32M
Schimbare (1 zi)
0.69%
Schimbare (1 an)
289.29%
Țară
US
Tranzacționează Relmada Therapeutics, Inc. (RLMD)

Categorie

Istoric al prețului acțiunii pentru Relmada Therapeutics, Inc. (RLMD)
Cel mai mare preț de închidere: $4.68 pe 2026-08-01

Cel mai mic preț de închidere: $11.43 pe 2014-06-01
Istoric al prețului acțiunii pentru Relmada Therapeutics, Inc. din 2014 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 10.22%
2025 860.47%
2024 -36.35%
2023 -17.50%
2022 -78.37%
2021 -41.31%
2020 -14.84%
2019 756.21%
2018 52.34%
2017 -6.63%
2016 -71.17%
2015 -80.90%
2014 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -13.08%
AU
$138.80 476.17%
US
$749.90 5.87%
CH